Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas.
about
Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literatureComparative study of matrix metalloproteinase expression between African American and Caucasian WomenInhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expressionCorrelation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.Metalloproteinases and tissue inhibitors of metalloproteinases.The plasmin cascade and matrix metalloproteinases in non-small cell lung cancerMatrix metalloproteinases in tumour invasion and metastasis.Clinical and pathologic factors predicting axillary lymph node involvement in breast cancer.Current concepts in cyclooxygenase inhibition in breast cancer.Inorganic sulfur reduces the motility and invasion of MDA-MB-231 human breast cancer cellsThe RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes.Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis.Plasma Levels and Diagnostic Utility of Macrophage Colony-Stimulating Factor, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinases-1 as New Biomarkers of Breast Cancer.Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma.Positron emission tomography tracers for imaging angiogenesis.Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C.MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factorsEvaluation of a triple-helical peptide with quenched FluorSophores for optical imaging of MMP-2 and MMP-9 proteolytic activity.Gynura procumbens ethanolic extract suppresses osteosarcoma cell proliferation and metastasis in vitroIn vivo investigation of hybrid Paclitaxel nanocrystals with dual fluorescent probes for cancer theranostics.The RhoA pathway mediates MMP-2 and MMP-9-independent invasive behavior in a triple-negative breast cancer cell line.Leptin utilizes Jun N-terminal kinases to stimulate the invasion of MCF-7 breast cancer cells.Catalyser-21(TM), a mineral water derived from leaf soil, inhibits tumor cell invasion and angiogenesis.Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells.Localization of gelatinolytic activity can be detected in breast cancer tissues by film in situ zymography.Metastatic ability of MXT mouse mammary subpopulations correlates with clonal expression and/or membrane-association of gelatinase A.Multimodality Imaging in Tumor Angiogenesis: Present Status and PerspectivesPolymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.Clinical relevance of serum levels of matrix metallopeptidase-2, and tissue inhibitor of metalloproteinase-1 and -2 in patients with malignant melanoma.
P2860
Q24652514-C150B46C-AF9B-400A-881F-7DB721B05A17Q24804813-F5968A01-C778-44DA-B135-A10E8912224BQ28199319-B02ECED3-B6C5-4B31-B9C5-CFBDF0232C28Q30857076-7D841F13-6591-4D26-859A-298EF2F557E3Q33538435-DF3C55E2-B9AD-48FE-8B35-C8FA890534B5Q33634208-2484E10F-4BD6-46E0-8AFF-4704067E01A3Q33765792-30C01874-A395-4D29-96FD-3341C3F794C7Q34058934-B26BB13A-0DAF-47B9-84AD-7C146632A7B6Q34969789-A141DC28-8F69-4079-AD86-25DAAEA9B8B4Q35566460-D6F2370F-A923-456E-B8A3-99F5C411F42FQ36174568-295EAD7D-B9EF-49EE-AAF0-C8C1121EE4A4Q36620240-F0E7E65E-7E76-4F54-9824-DCD3A0E8FD5FQ36636689-1F174690-30CF-476E-A781-598029508D56Q36671053-D9660E97-248B-4AAA-84FE-7289B5419BD0Q36777285-C1FC5F7E-6864-475C-91FC-6291B3F0AAADQ36986233-A871C921-50EB-416C-8507-7DB41A0E1EA9Q37600292-570A112C-DF52-4F4A-8F77-DC06879C1D48Q38981765-8C894CF8-CB1E-4677-B6E2-CF4380515D07Q39110122-5B862E05-B83A-406B-936E-915A9CAEC241Q39160197-E1CC1E76-E484-4FEC-BC33-ED6F8C7E1810Q39223186-CDC8AE15-428D-4B81-801E-CB7F89FAEE84Q39900881-A4917261-0EF2-49E5-B4DF-52A9DA5060DDQ39918362-ED2BAA5D-1B35-4D94-8BD2-8B6D9B1204D6Q40612563-9BAE357C-60B3-48B2-8EE6-E0B58017E87BQ40709129-E1C1938E-58D9-409E-BEFA-D3030C5C4628Q41112578-EEDE6377-F27F-44C2-9E35-B93795DAF490Q41661199-1F604EA8-66BB-43B2-913A-4E9067209DECQ46788870-608CC215-D57A-4F42-9D2E-2E55E9F97249Q51706058-AA36B1D1-1684-41AB-8B67-EDB2B45CAF28
P2860
Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Production of matrix metallopr ...... es in human breast carcinomas.
@en
Production of matrix metallopr ...... es in human breast carcinomas.
@nl
type
label
Production of matrix metallopr ...... es in human breast carcinomas.
@en
Production of matrix metallopr ...... es in human breast carcinomas.
@nl
prefLabel
Production of matrix metallopr ...... es in human breast carcinomas.
@en
Production of matrix metallopr ...... es in human breast carcinomas.
@nl
P2093
P2860
P1476
Production of matrix metallopr ...... es in human breast carcinomas.
@en
P2093
P2860
P304
P356
10.1111/J.1349-7006.1996.TB00266.X
P577
1996-06-01T00:00:00Z